Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Aug 15;318(Pt 1):255–261. doi: 10.1042/bj3180255

The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).

J C O'Connell 1, J F McCallum 1, I McPhee 1, J Wakefield 1, E S Houslay 1, W Wishart 1, G Bolger 1, M Frame 1, M D Houslay 1
PMCID: PMC1217616  PMID: 8761480

Abstract

The PDE4A (type IV) cAMP-specific, rolipram-inhibited phosphodiesterase RPDE-6 (RNPDE4A5), when transiently expressed in COS7 cells, could be complexed with the v-Src-SH3 domain expressed as a glutathione S-transferase (GST) fusion protein. RPDE-6 did not interact with GST itself. This complex was not disrupted by treatment with high NaCl concentration together with Triton X-100. Interaction was apparently determined by the N-terminal splice region of RPDE-6, as the PDE4A splice variant RPDE-39, which differs from RPDE-6 at the extreme N-terminus, failed to associate with v-Src-SH3; met26RD1 (where RD1 is rat 'dunc-like' PDE), which has the N-terminal splice region deleted, failed to associate with v-Src-SH3, and the association of RPDE-6 and v-Src-SH3 was blocked by a fusion protein formed from the N-terminal splice region. RDPE-6 showed binding to GST fusion proteins of both the intact Src kinase and an SH2-SH3 construct but did not bind to the Src-SH2 domain or to the adaptor protein Grb-2. RPDE-6 could be co-immunoprecipitated from cytosol extracts of transfected cells by using anti-Src antiserum. RPDE-6 exhibited selectivity in binding to the SH3 domains of c-Abl, Crk, Csk, Lck, Lyn, Fyn and v-Src, with binding to the SH3 regions of the Src-related tyrosyl kinases Lyn and Fyn being the most effective. The binding of RPDE-6 to the SH3 domains of Crk, Csk and Lck led to a marked reduction in PDE activity, but no change was apparent in complexes with other species. Endogenous RPDE-6 from brain, but not endogenous RPDE-39 from testis, bound to the Src-SH3 domain. We suggest that the PDE4A splice variant RPDE-6 has a propensity for interaction with selective SH3 domains, in particular those from Src and the Src-related tyrosyl kinases Lyn and Fyn. This interaction seems to be governed by alternative splicing of the PDE4A gene, because RPDE-39, a splice variant that lacks the proline-rich N-terminal splice region of RPDE-6, does not interact with these SH3 domains. It is proposed that the binding site on RPDE-6 for SH3 domains lies within the unique first 102 residues of its N-terminal splice domain, where two motifs representing Class I SH3 binding sites with selectivity for Src kinase SH3 domains can be identified and one motif for a putative Class II SH3 binding site.

Full Text

The Full Text of this article is available as a PDF (418.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandropoulos K., Cheng G., Baltimore D. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3110–3114. doi: 10.1073/pnas.92.8.3110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beavo J. A., Conti M., Heaslip R. J. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 1994 Sep;46(3):399–405. [PubMed] [Google Scholar]
  3. Bolen J. B. Nonreceptor tyrosine protein kinases. Oncogene. 1993 Aug;8(8):2025–2031. [PubMed] [Google Scholar]
  4. Bolger G. B., McPhee I., Houslay M. D. Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8. J Biol Chem. 1996 Jan 12;271(2):1065–1071. doi: 10.1074/jbc.271.2.1065. [DOI] [PubMed] [Google Scholar]
  5. Bolger G. B. Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes. Cell Signal. 1994 Nov;6(8):851–859. doi: 10.1016/0898-6568(94)90018-3. [DOI] [PubMed] [Google Scholar]
  6. Booker G. W., Gout I., Downing A. K., Driscoll P. C., Boyd J., Waterfield M. D., Campbell I. D. Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell. 1993 May 21;73(4):813–822. doi: 10.1016/0092-8674(93)90259-s. [DOI] [PubMed] [Google Scholar]
  7. Borchert T. V., Mathieu M., Zeelen J. P., Courtneidge S. A., Wierenga R. K. The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop. FEBS Lett. 1994 Mar 14;341(1):79–85. doi: 10.1016/0014-5793(94)80244-0. [DOI] [PubMed] [Google Scholar]
  8. Bougeret C., Rothhut B., Jullien P., Fischer S., Benarous R. Recombinant Csk expressed in Escherichia coli is autophosphorylated on tyrosine residue(s). Oncogene. 1993 May;8(5):1241–1247. [PubMed] [Google Scholar]
  9. Bushman W. A., Wilson L. K., Luttrell D. K., Moyers J. S., Parsons S. J. Overexpression of c-src enhances beta-adrenergic-induced cAMP accumulation. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7462–7466. doi: 10.1073/pnas.87.19.7462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chou M. M., Hanafusa H. A novel ligand for SH3 domains. The Nck adaptor protein binds to a serine/threonine kinase via an SH3 domain. J Biol Chem. 1995 Mar 31;270(13):7359–7364. doi: 10.1074/jbc.270.13.7359. [DOI] [PubMed] [Google Scholar]
  11. Collett M. S., Erikson E., Erikson R. L. Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation. J Virol. 1979 Feb;29(2):770–781. doi: 10.1128/jvi.29.2.770-781.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cooper D. M., Mons N., Fagan K. Ca(2+)-sensitive adenylyl cyclases. Cell Signal. 1994 Nov;6(8):823–840. doi: 10.1016/0898-6568(94)90016-7. [DOI] [PubMed] [Google Scholar]
  13. Courtneidge S. A., Fumagalli S., Koegl M., Superti-Furga G., Twamley-Stein G. M. The Src family of protein tyrosine kinases: regulation and functions. Dev Suppl. 1993:57–64. [PubMed] [Google Scholar]
  14. Cross F. R., Hanafusa H. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation. Cell. 1983 Sep;34(2):597–607. doi: 10.1016/0092-8674(83)90392-6. [DOI] [PubMed] [Google Scholar]
  15. Goudreau N., Cornille F., Duchesne M., Parker F., Tocqué B., Garbay C., Roques B. P. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nat Struct Biol. 1994 Dec;1(12):898–907. doi: 10.1038/nsb1294-898. [DOI] [PubMed] [Google Scholar]
  16. Guruprasad L., Dhanaraj V., Timm D., Blundell T. L., Gout I., Waterfield M. D. The crystal structure of the N-terminal SH3 domain of Grb2. J Mol Biol. 1995 May 12;248(4):856–866. doi: 10.1006/jmbi.1995.0266. [DOI] [PubMed] [Google Scholar]
  17. Haefner B., Baxter R., Fincham V. J., Downes C. P., Frame M. C. Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain. J Biol Chem. 1995 Apr 7;270(14):7937–7943. doi: 10.1074/jbc.270.14.7937. [DOI] [PubMed] [Google Scholar]
  18. Horton Y. M., Sullivan M., Houslay M. D. Molecular cloning of a novel splice variant of human type IVA (PDE-IVA) cyclic AMP phosphodiesterase and localization of the gene to the p13.2-q12 region of human chromosome 19 [corrected]. Biochem J. 1995 Jun 1;308(Pt 2):683–691. doi: 10.1042/bj3080683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Lemmon M. A., Ladbury J. E., Mandiyan V., Zhou M., Schlessinger J. Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. J Biol Chem. 1994 Dec 16;269(50):31653–31658. [PubMed] [Google Scholar]
  21. Luttrell D. K., Hausdorff W. P., Moyers J. E., Gilmer T. M., Parsons S. J., Caron M. G., Lefkowitz R. J. Overexpression of pp60c-src is associated with altered regulation of adenylyl cyclase. Cell Signal. 1992 Sep;4(5):531–541. doi: 10.1016/0898-6568(92)90022-z. [DOI] [PubMed] [Google Scholar]
  22. Manganiello V. C., Taira M., Degerman E., Belfrage P. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell Signal. 1995 Jul;7(5):445–455. doi: 10.1016/0898-6568(95)00017-j. [DOI] [PubMed] [Google Scholar]
  23. Mayer B. J., Baltimore D. Signalling through SH2 and SH3 domains. Trends Cell Biol. 1993 Jan;3(1):8–13. doi: 10.1016/0962-8924(93)90194-6. [DOI] [PubMed] [Google Scholar]
  24. McPhee I., Pooley L., Lobban M., Bolger G., Houslay M. D. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem J. 1995 Sep 15;310(Pt 3):965–974. doi: 10.1042/bj3100965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Milatovich A., Bolger G., Michaeli T., Francke U. Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse. Somat Cell Mol Genet. 1994 Mar;20(2):75–86. doi: 10.1007/BF02290677. [DOI] [PubMed] [Google Scholar]
  26. Monaco L., Vicini E., Conti M. Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. Multiple mRNA variants originate from alternative splicing and multiple start sites. J Biol Chem. 1994 Jan 7;269(1):347–357. [PubMed] [Google Scholar]
  27. Moyers J. S., Bouton A. H., Parsons S. J. The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src. Mol Cell Biol. 1993 Apr;13(4):2391–2400. doi: 10.1128/mcb.13.4.2391-2400.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Musacchio A., Gibson T., Lehto V. P., Saraste M. SH3--an abundant protein domain in search of a function. FEBS Lett. 1992 Jul 27;307(1):55–61. doi: 10.1016/0014-5793(92)80901-r. [DOI] [PubMed] [Google Scholar]
  29. Parsons J. T., Weber M. J. Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr Top Microbiol Immunol. 1989;147:79–127. doi: 10.1007/978-3-642-74697-0_3. [DOI] [PubMed] [Google Scholar]
  30. Patschinsky T., Hunter T., Sefton B. M. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus. J Virol. 1986 Jul;59(1):73–81. doi: 10.1128/jvi.59.1.73-81.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pawson T., Gish G. D. SH2 and SH3 domains: from structure to function. Cell. 1992 Oct 30;71(3):359–362. doi: 10.1016/0092-8674(92)90504-6. [DOI] [PubMed] [Google Scholar]
  32. Ramos-Morales F., Druker B. J., Fischer S. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes. Oncogene. 1994 Jul;9(7):1917–1923. [PubMed] [Google Scholar]
  33. Rivero-Lezcano O. M., Sameshima J. H., Marcilla A., Robbins K. C. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J Biol Chem. 1994 Jul 1;269(26):17363–17366. [PubMed] [Google Scholar]
  34. Scotland G., Houslay M. D. Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVA1) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase. Biochem J. 1995 Jun 1;308(Pt 2):673–681. doi: 10.1042/bj3080673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shakur Y., Pryde J. G., Houslay M. D. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem J. 1993 Jun 15;292(Pt 3):677–686. doi: 10.1042/bj2920677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Shakur Y., Wilson M., Pooley L., Lobban M., Griffiths S. L., Campbell A. M., Beattie J., Daly C., Houslay M. D. Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem J. 1995 Mar 15;306(Pt 3):801–809. doi: 10.1042/bj3060801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Taussig R., Gilman A. G. Mammalian membrane-bound adenylyl cyclases. J Biol Chem. 1995 Jan 6;270(1):1–4. doi: 10.1074/jbc.270.1.1. [DOI] [PubMed] [Google Scholar]
  38. Terasawa H., Kohda D., Hatanaka H., Tsuchiya S., Ogura K., Nagata K., Ishii S., Mandiyan V., Ullrich A., Schlessinger J. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos. Nat Struct Biol. 1994 Dec;1(12):891–897. doi: 10.1038/nsb1294-891. [DOI] [PubMed] [Google Scholar]
  39. Yang B., Jung D., Motto D., Meyer J., Koretzky G., Campbell K. P. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem. 1995 May 19;270(20):11711–11714. doi: 10.1074/jbc.270.20.11711. [DOI] [PubMed] [Google Scholar]
  40. Yu H., Rosen M. K., Schreiber S. L. 1H and 15N assignments and secondary structure of the Src SH3 domain. FEBS Lett. 1993 Jun 7;324(1):87–92. doi: 10.1016/0014-5793(93)81538-b. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES